Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Stilgenbauer

Showing results (171-180 of 466) with videos related to

Pageof 47
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2010
TP53 mutation and survival in chronic lymphocytic leukemiaThorsten Zenz, Barbara Eichhorst, Raymonde Busch, et al.
Blood|December 18, 2012
Telomere length in mantle cell lymphomaBilly Michael Chelliah Jebaraj, Dirk Kienle, André Lechel, et al.
Plos One|February 6, 2013
Germline allele-specific expression of DAPK1 in chronic lymphocytic leukemiaQuan-Xiang Wei, Rainer Claus, Thomas Hielscher, et al.
Haematologica|June 2, 2017
Immunoglobulin genes in chronic lymphocytic leukemia: key to understanding the disease and improving risk stratificationLesley-Ann Sutton, Anastasia Hadzidimitriou, Panagiotis Baliakas, et al.
Cancers|April 23, 2022
Deep Neural Networks and Machine Learning Radiomics Modelling for Prediction of Relapse in Mantle Cell LymphomaCatharina Silvia Lisson, Christoph Gerhard Lisson, Marc Fabian Mezger, et al.
Blood|October 23, 2008
miR-34a as part of the resistance network in chronic lymphocytic leukemiaThorsten Zenz, Julia Mohr, Eric Eldering, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 18, 2008
First demonstration of leukemia imaging with the proliferation marker 18F-fluorodeoxythymidineAndreas K Buck, Martin Bommer, Malik E Juweid, et al.
Haematologica|July 7, 2018
Safety of obinutuzumab alone or combined with chemotherapy for previously untreated or relapsed/refractory chronic lymphocytic leukemia in the phase IIIb GREEN studyVéronique Leblond, Melih Aktan, Christelle M Ferra Coll, et al.
Blood|December 5, 2018
<i>FBXW7</i> mutations reduce binding of NOTCH1, leading to cleaved NOTCH1 accumulation and target gene activation in CLLViola Close, William Close, Sabrina Julia Kugler, et al.
Blood|June 19, 2004
Graft-versus-leukemia activity may overcome therapeutic resistance of chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene status: implications of minimal residual disease measurement with quantitative PCRMatthias Ritgen, Stephan Stilgenbauer, Nils von Neuhoff, et al.
Pageof 47

Showing results (171-180 of 466) with videos related to

Sort By:
Pageof 47
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2010
TP53 mutation and survival in chronic lymphocytic leukemiaThorsten Zenz, Barbara Eichhorst, Raymonde Busch, et al.
Blood|December 18, 2012
Telomere length in mantle cell lymphomaBilly Michael Chelliah Jebaraj, Dirk Kienle, André Lechel, et al.
Plos One|February 6, 2013
Germline allele-specific expression of DAPK1 in chronic lymphocytic leukemiaQuan-Xiang Wei, Rainer Claus, Thomas Hielscher, et al.
Haematologica|June 2, 2017
Immunoglobulin genes in chronic lymphocytic leukemia: key to understanding the disease and improving risk stratificationLesley-Ann Sutton, Anastasia Hadzidimitriou, Panagiotis Baliakas, et al.
Cancers|April 23, 2022
Deep Neural Networks and Machine Learning Radiomics Modelling for Prediction of Relapse in Mantle Cell LymphomaCatharina Silvia Lisson, Christoph Gerhard Lisson, Marc Fabian Mezger, et al.
Blood|October 23, 2008
miR-34a as part of the resistance network in chronic lymphocytic leukemiaThorsten Zenz, Julia Mohr, Eric Eldering, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 18, 2008
First demonstration of leukemia imaging with the proliferation marker 18F-fluorodeoxythymidineAndreas K Buck, Martin Bommer, Malik E Juweid, et al.
Haematologica|July 7, 2018
Safety of obinutuzumab alone or combined with chemotherapy for previously untreated or relapsed/refractory chronic lymphocytic leukemia in the phase IIIb GREEN studyVéronique Leblond, Melih Aktan, Christelle M Ferra Coll, et al.
Blood|December 5, 2018
<i>FBXW7</i> mutations reduce binding of NOTCH1, leading to cleaved NOTCH1 accumulation and target gene activation in CLLViola Close, William Close, Sabrina Julia Kugler, et al.
Blood|June 19, 2004
Graft-versus-leukemia activity may overcome therapeutic resistance of chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene status: implications of minimal residual disease measurement with quantitative PCRMatthias Ritgen, Stephan Stilgenbauer, Nils von Neuhoff, et al.
Pageof 47